Gennex Laboratories Ltd. key Products/Revenue Segments include Bulk Drugs (Intermediates) for the year ending 31-Mar-2023.For the quarter ended 30-06-2024, the company has reported a Consolidated ...
Some results have been hidden because they may be inaccessible to you